Cytarabine

CAS Number: 147-94-4

Molecular Formula: C9H13N3O5

About Cytarabine

Cytarabine (CAS 147-94-4) serves as a critical antimetabolite in the United States oncology sector, where high purity fine chemicals with >= 99% pharma purity are essential for the induction and consolidation therapy of acute myeloid leukemia (AML). 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinone has seen a surge ...

Cytarabine Specifications

CAS Number

147-94-4

Molecular Formula

C9H13N3O5

Molecular Weight

243.22 g/mol

IUPAC Name

4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one

Canonical SMILES

C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O

InChI Key

UHDGCWIWMRVCDJ-CCXZUQQUSA-N

CAS Number

147-94-4

Molecular Formula

C9H13N3O5

Molecular Weight

243.22 g/mol

IUPAC Name

4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one

Canonical SMILES

C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O

InChI Key

UHDGCWIWMRVCDJ-CCXZUQQUSA-N

Molecular Weight

243.22 g/mol

Antineoplastic Agent

An essential antimetabolite and pyrimidine nucleoside analog primarily utilized for the induction and maintenance of remission in acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), and the blast phase of chronic myeloid leukemia (CML)

Chemotherapeutic Ingredient

A critical active pharmaceutical ingredient used in multiagent regimens to treat various hematologic malignancies, including Hodgkin and non-Hodgkin lymphomas

Intrathecal Therapy Agent

A specialized medication administered directly into the cerebrospinal fluid for the prophylaxis and treatment of meningeal leukemia and neoplastic meningitis

Biological Research Tool

A high-purity nucleoside analog employed in cell culture studies to inhibit DNA polymerase and control glial cell proliferation in neurological research.